Tooth decay: Mouthwash turns your teeth blue when it’s time to go to the dentist
A mouthwash solution containing ferumoxytol and a dye could treat, prevent, and diagnose tooth decay, according to UPenn researchers.
Brain implant lets cancer patients try 20 different drugs at a time
A microdevice that injects up to 20 drugs into gliomas at once could help doctors quickly identify the best treatment for cancer patients.
Popular weight-loss drugs show promise as addiction treatments
New trials will test the ability of GLP-1 agonists, a popular class of weight-loss drugs, to help people beat addictions to drugs and alcohol.
Australian ant honey inhibits tough pathogens, new research shows
Honeypot ant honey may help develop our arsenal of effective antibacterial and antifungal treatments, which are increasingly vital.
New treatment slashes obesity in mice eating fatty, sugary diet
A new obesity treatment developed at UMass triggered weight loss in mice even as they continued to eat a diet high in fat and sugar.
Transplants of lab-grown brain cells reduce Parkinson’s symptoms
Transplants of lab-grown dopamine neurons reduced the amount of time people experienced Parkinson’s symptoms in a small trial.
World-first experiment shows genetically engineered bacteria detecting cancer
Genetically engineered bacteria could be used to detect a range of different diseases, particularly infections and cancers.
Scientists make pain relievers like Tylenol from pine trees rather than fossil fuels
Chemists have shown how to manufacture ibuprofen and acetaminophen using a waste product from the forestry and paper industries.
Weight-loss drug cut the risk of heart attack and stroke by 20% in large trial
The weight-loss drug semaglutide reduced patients’ risk of heart attacks, strokes, or death from heart disease by 20% in a large trial.
Fragile X syndrome often results from improperly processed genetic material
Researchers discovered that the mutated gene responsible for fragile X syndrome is active in most people with the disorder, not silenced.
Study finds tracking brain waves could reduce post-op complications
Researchers found brain wave signatures that could help determine when patients are transitioning into a deep state of unconsciousness.
Immune cells in the brain may reduce damage during seizures and promote recovery
Microglia perform many functions in the brain, and their role in seizures is unclear — a new study in mice aims to find out more.
New RSV shot protects babies against dangerous lung infections
The FDA has approved nirsevimab, an RSV shot that protects babies against the leading cause of infant hospitalizations in the US.
Radioactive drugs are transforming cancer treatment
Radiopharmaceuticals allow doctors to directly target patients' cancer cells and avoid healthy tissue typically damaged by radiation therapy.
Not all repellents are equal – here’s how to avoid mosquito bites this summer
Researchers studied different types of mosquito repellents and their efficacy for over a decade. Here's what they found.
A functional cure for brittle diabetes is now available in the US
Islet transplantation, a procedure shown to functionally cure some people with hard-to-control brittle diabetes, has been approved in the US.
Newly identified type of depression affects 27% of patients
Stanford University researchers have identified a new, hard-to-treat type of depression characterized by problems with cognition.
“Backdoor” into the ear offers new hope for reversing deafness
A new study has unlocked a “backdoor” into the inner ear that could make administering gene therapies to restore hearing less risky.
One shot epilepsy treatment reduced seizures by 95% in first two patients
A stem cell-based treatment for epilepsy slashed the number of seizures experienced by two trial participants by 95%.
SpaceX successfully launches world’s first “space factory”
SpaceX has successfully deployed a “space factory” developed by startup Varda Space Industries to manufacture drugs in microgravity.
Made-to-fade tattoo ink keeps cancer therapy from leaving a mark
Henry Ford Health researchers are using temporary tattoo ink to help radiation therapy patients for whom permanent tattoos may not be an option.
The placenta may play a role in the genetic risk of schizophrenia
Researchers at Johns Hopkins have found that genes associated with schizophrenia risk may impact the placenta, not just the brain.
Gain-of-function research is more than just tweaking risky viruses
Gain-of-function experiments in the lab can help researchers get ahead of viruses naturally gaining the ability to infect people in the wild.
Chronic pain can be objectively measured using brain signals
Even though pain is universal and we know it happens in the brain, we've never before had a way to objectively measure its intensity.
This “bridge” between chemo and cancer solves a big problem for treatment
To improve leukemia treatment, Australian researchers have created a bispecific antibody that connects chemo drugs to cancer cells.
Personalized mRNA vaccine preps the body to battle deadly cancer
A new pancreatic cancer vaccine based on mRNA tech was shown to be safe and capable of triggering an immune response in a small trial.
Ultrasound could help us fight the deadliest cancer
In a small study, Northwestern researchers were able to get chemo drugs into the brains of glioblastoma patients with implanted ultrasound devices.
AI dramatically improved mRNA vaccines in just 11 minutes
A new AI tool can find the most stable mRNA sequence for a vaccine, leading to more effective shots that are less prone to degradation.
The first fecal transplant pill is heading to pharmacies
The FDA approval of the first fecal transplant pill could kick off an era in which we target the gut microbiome to treat many other diseases.
Gene therapy reverses vision loss in primates — by making their eyes young again
A Harvard study found that a new gene therapy that reprograms cells to their younger state can reverse NAION-caused vision loss in primates.
Two African countries first to approve Oxford’s malaria vaccine, with 20 million doses on the way
Ghana and Nigeria have become the first two nations to approve Oxford’s vaccine against malaria.
Hollow “seed” shrinks cancerous tumors from the inside
A new drug delivery system for pancreatic tumors could dramatically decrease medication dosages, helping minimize unpleasant side effects.
Alzheimer’s disease: an illness that needs a long overdue cocktail
Scientists are starting to agree that the "holy grail" solution for Alzheimer's is more likely to be a drug cocktail than a single treatment.
One shot could stop severe bleeding and save thousands of lives
A potentially lifesaving treatment to stop severe postpartum hemorrhage could soon be more accessible to the people who need it the most.
One way to speed up clinical trials: Skip right to the data with electronic medical records
It takes around 17 years for medical research to translate into clinical practice — why not use EMR data to speed things up?
New drug delivery tech could ensure you never forget your meds
Rice University's new drug delivery tech uses biodegradable microparticles to administer medications exactly when and where they are needed.
Tuberculosis kills over a million people a year. New breakthroughs may help humanity fight back.
The world needs a tuberculosis vaccine, but the challenge trials that could help are impossible to run. Two new approaches look to change that.
Epilepsy surgery has a success rate of only 50%. This digital brain may change that.
Using patient data and AI, French researchers have created a digital model of the brain to figure out which brain region needs removed.
Viruses cause 200+ diseases. This one drug may be able to treat them all.
New Zealand-based startup Kimer Med wants to create an antiviral that would be effective against many known viruses — and unknown.
Narcan is now available over-the-counter in the US
Naloxone administered by nasal spray can be a lifesaving drug with minimal side effects. It's now approved for over-the-counter use in the U.S.
A single injection of stem cells slashes risk of heart attack or stroke by 58%
An injection of stem cells reduced the risk of heart attack or stroke by 58% in a trial of people with heart failure.
Volunteers were purposefully infected with COVID-19. Was it worth it?
It has been a year since the first COVID human challenge data was published. What did we learn, and can HCTs prepare us for the future?
Tirzepatide: A novel obesity drug ushers in a new era of weight loss — because this one works
Patients who received tirzepatide in a recent clinical study lost more than 20% of their body weight (52 pounds, or 23.6 kg).